Cargando…
Signature biomarker states and mortality among hospitalized SARS-CoV-2-infected patients
Autores principales: | Selvaggi, Caitlin, Harrison, Linda J., Kim, Eunyoung, Reilly, Muredach P., Foulkes, Andrea S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733911/ https://www.ncbi.nlm.nih.gov/pubmed/34989977 http://dx.doi.org/10.1007/s40620-021-01239-z |
Ejemplares similares
-
Biomarkers of Cardiac Injury, Renal Injury, and Inflammation Are Strong Mediators of Sex-Associated Death in COVID-19
por: Lumish, Heidi S., et al.
Publicado: (2022) -
Functional principal component analysis and sparse-group LASSO to identify associations between biomarker trajectories and mortality among hospitalized SARS-CoV-2 infected individuals
por: Cao, Tingyi, et al.
Publicado: (2023) -
Response to Letter to the Editor From Nelson et al: “Understanding the Link Between Obesity and Severe COVID-19 Outcomes: Causal Mediation by Systemic Inflammatory Response”
por: Foulkes, Andrea S, et al.
Publicado: (2022) -
Don’t blame the nails for SARS-CoV-2 hospitalizations and mortality
por: Desai, Amar D., et al.
Publicado: (2022) -
Statins Are Associated with Improved 28-day Mortality in Patients Hospitalized with SARS-CoV-2 Infection
por: Memel, Zoe N., et al.
Publicado: (2021)